[(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-5-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-6-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-[1-(2-methoxyethyl)indol-2-yl]-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-(2-methylpropyl)indol-2-yl]benzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-[(1-methylpyrazol-4-yl)methyl]indol-2-yl]benzimidazol-5-yl]methanone

C128H147N27O6 — CID 162151140

IUPAC[(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-5-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-6-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-[1-(2-methoxyethyl)indol-2-yl]-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-(2-methylpropyl)indol-2-yl]benzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-[(1-methylpyrazol-4-yl)methyl]indol-2-yl]benzimidazol-5-yl]methanone
SMILESCC(C)Cn1c(-c2nc3cc(C(=O)N4CCC[C@@H](N)C4)ccc3n2C)cc2ccccc21.CCn1c(-c2nc3cc(C(=O)N4CCC[C@@H](N)C4)ccc3n2C)cc2cc(C)ccc21.CCn1c(-c2nc3cc(C(=O)N4CCC[C@@H](N)C4)ccc3n2C)cc2ccc(C)cc21.COCCn1c(-c2nc3cc(C(=O)N4CCC[C@@H](N)C4)ccc3n2C)cc2ccccc21.Cn1cc(Cn2c(-c3nc4cc(C(=O)N5CCC[C@@H](N)C5)ccc4n3C)cc3ccccc32)cn1
InChIInChI=1S/C27H29N7O.C26H31N5O.C25H29N5O2.2C25H29N5O/c1-31-15-18(14-29-31)16-34-23-8-4-3-6-19(23)13-25(34)26-30-22-12-20(9-10-24(22)32(26)2)27(35)33-11-5-7-21(28)17-33;1-17(2)15-31-22-9-5-4-7-18(22)14-24(31)25-28-21-13-19(10-11-23(21)29(25)3)26(32)30-12-6-8-20(27)16-30;1-28-22-10-9-18(25(31)29-11-5-7-19(26)16-29)14-20(22)27-24(28)23-15-17-6-3-4-8-21(17)30(23)12-13-32-2;1-4-30-21-9-7-16(2)12-18(21)14-23(30)24-27-20-13-17(8-10-22(20)28(24)3)25(31)29-11-5-6-19(26)15-29;1-4-30-22-12-16(2)7-8-17(22)14-23(30)24-27-20-13-18(9-10-21(20)28(24)3)25(31)29-11-5-6-19(26)15-29/h3-4,6,8-10,12-15,21H,5,7,11,16-17,28H2,1-2H3;4-5,7,9-11,13-14,17,20H,6,8,12,15-16,27H2,1-3H3;3-4,6,8-10,14-15,19H,5,7,11-13,16,26H2,1-2H3;2*7-10,12-14,19H,4-6,11,15,26H2,1-3H3/t21-;20-;3*19-/m11111/s1
InChIKeyZLFMSKUPMUXHAZ-UNMKSZRGSA-N
MW2159.77 g/mol
LogP19.53
Rot. Bonds19

About [(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-5-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-6-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-[1-(2-methoxyethyl)indol-2-yl]-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-(2-methylpropyl)indol-2-yl]benzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-[(1-methylpyrazol-4-yl)methyl]indol-2-yl]benzimidazol-5-yl]methanone

[(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-5-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-6-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-[1-(2-methoxyethyl)indol-2-yl]-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-(2-methylpropyl)indol-2-yl]benzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-[(1-methylpyrazol-4-yl)methyl]indol-2-yl]benzimidazol-5-yl]methanone (PubChem CID 162151140) has the molecular formula C128H147N27O6 and a molecular weight of 2159.77 g/mol. Its IUPAC name is [(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-5-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-6-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-[1-(2-methoxyethyl)indol-2-yl]-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-(2-methylpropyl)indol-2-yl]benzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-[(1-methylpyrazol-4-yl)methyl]indol-2-yl]benzimidazol-5-yl]methanone.

Molecular Properties

Compound Name[(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-5-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-6-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-[1-(2-methoxyethyl)indol-2-yl]-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-(2-methylpropyl)indol-2-yl]benzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-[(1-methylpyrazol-4-yl)methyl]indol-2-yl]benzimidazol-5-yl]methanone
PubChem CID162151140
Molecular FormulaC128H147N27O6
Molecular Weight2159.77 g/mol
Exact Mass2158.20
IUPAC Name[(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-5-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-6-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-[1-(2-methoxyethyl)indol-2-yl]-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-(2-methylpropyl)indol-2-yl]benzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-[(1-methylpyrazol-4-yl)methyl]indol-2-yl]benzimidazol-5-yl]methanone
SMILESCC(C)Cn1c(-c2nc3cc(C(=O)N4CCC[C@@H](N)C4)ccc3n2C)cc2ccccc21.CCn1c(-c2nc3cc(C(=O)N4CCC[C@@H](N)C4)ccc3n2C)cc2cc(C)ccc21.CCn1c(-c2nc3cc(C(=O)N4CCC[C@@H](N)C4)ccc3n2C)cc2ccc(C)cc21.COCCn1c(-c2nc3cc(C(=O)N4CCC[C@@H](N)C4)ccc3n2C)cc2ccccc21.Cn1cc(Cn2c(-c3nc4cc(C(=O)N5CCC[C@@H](N)C5)ccc4n3C)cc3ccccc32)cn1
InChIInChI=1S/C27H29N7O.C26H31N5O.C25H29N5O2.2C25H29N5O/c1-31-15-18(14-29-31)16-34-23-8-4-3-6-19(23)13-25(34)26-30-22-12-20(9-10-24(22)32(26)2)27(35)33-11-5-7-21(28)17-33;1-17(2)15-31-22-9-5-4-7-18(22)14-24(31)25-28-21-13-19(10-11-23(21)29(25)3)26(32)30-12-6-8-20(27)16-30;1-28-22-10-9-18(25(31)29-11-5-7-19(26)16-29)14-20(22)27-24(28)23-15-17-6-3-4-8-21(17)30(23)12-13-32-2;1-4-30-21-9-7-16(2)12-18(21)14-23(30)24-27-20-13-17(8-10-22(20)28(24)3)25(31)29-11-5-6-19(26)15-29;1-4-30-22-12-16(2)7-8-17(22)14-23(30)24-27-20-13-18(9-10-21(20)28(24)3)25(31)29-11-5-6-19(26)15-29/h3-4,6,8-10,12-15,21H,5,7,11,16-17,28H2,1-2H3;4-5,7,9-11,13-14,17,20H,6,8,12,15-16,27H2,1-3H3;3-4,6,8-10,14-15,19H,5,7,11-13,16,26H2,1-2H3;2*7-10,12-14,19H,4-6,11,15,26H2,1-3H3/t21-;20-;3*19-/m11111/s1
InChIKeyZLFMSKUPMUXHAZ-UNMKSZRGSA-N
XLogP19.53
TPSA372.45 Ų
H-Bond Donors5
H-Bond Acceptors28
Rotatable Bonds19
Heavy Atoms161
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002159.77
LogP ≤ 519.53
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1028

Analyze [(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-5-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-6-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-[1-(2-methoxyethyl)indol-2-yl]-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-(2-methylpropyl)indol-2-yl]benzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-[(1-methylpyrazol-4-yl)methyl]indol-2-yl]benzimidazol-5-yl]methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

US20240025884, Example 416
CID 170672804
US20240025884, Example 425
CID 170673178
3-[7-(difluoromethyl)-6-[1-[2-[[3-[6-[1-methyl-5-[[4-[2-[6-(1-methylpyrazol-4-yl)-3,4-dihydro-2H-quinolin-1-yl]-5H-pyrrolo[2,3-b]pyrazin-7-yl]pyrazol-1-yl]methyl]pyrazol-4-yl]-3,4-dihydro-2H-quinolin-1-yl]-1-(oxan-4-yl)indazole-5-carbonyl]amino]ethyl]pyrazol-4-yl]-3,4-dihydro-2H-quinolin-1-yl]-N-methyl-1-(oxan-4-yl)indazole-5-carboxamide
CID 132181733
4-[8-amino-3-[(2S)-1-[(E)-4-(dimethylamino)but-2-enoyl]piperidin-2-yl]-6-[(Z)-3-[3-[6-[4-(morpholine-4-carbonyl)anilino]-1H-pyrazolo[3,4-d]pyrimidin-4-yl]anilino]-3-oxoprop-1-enyl]imidazo[1,5-a]pyrazin-1-yl]-N-[4-(trifluoromethyl)pyridin-2-yl]benzamide
CID 134366254
2-[7-(difluoromethyl)-4-[2-[5-[7-(difluoromethyl)-4-[2-[5-[7-(difluoromethyl)-6-(1-methylpyrazol-4-yl)-3,4-dihydro-2H-quinolin-1-yl]-3-(methylcarbamoyl)-1H-pyrrolo[2,3-c]pyridin-7-yl]propyl]-6-(1-methylpyrazol-4-yl)-3,4-dihydro-2H-quinolin-1-yl]-3-(methylcarbamoyl)-1H-indol-7-yl]propyl]-6-(1-methylpyrazol-4-yl)-3,4-dihydro-2H-quinolin-1-yl]-N,5-dimethylpyrrolo[3,2-d]pyrimidine-7-carboxamide
CID 138655261
5,6-dihydro-4H-pyrrolo[3,4-c]pyrazol-2-yl-[6-[[5-fluoro-4-[8-[6-[[5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]amino]pyridine-3-carbonyl]-3,8-diazabicyclo[3.2.1]octan-2-yl]-6-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]amino]-3-pyridinyl]methanone
CID 145006836
4-(7-fluoroimidazo[1,2-a]pyridin-3-yl)-7-[[5-[(1S)-2-[7-fluoro-3-[7-[[5-[(1R)-1-morpholin-4-ylethyl]-2-pyridinyl]amino]-1-oxo-2,3-dihydroisoindol-4-yl]imidazo[1,2-a]pyridin-8-yl]-1-morpholin-4-ylethyl]-2-pyridinyl]amino]-2,3-dihydroisoindol-1-one
CID 156418516
2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-[5-[4-[4-[2-[4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-1-methylindazol-6-yl]piperidin-1-yl]acetyl]piperazin-1-yl]phenyl]-7-fluoro-3-oxo-1H-isoindol-2-yl]-N-pyridin-2-ylacetamide
CID 156515673
2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-[5-[4-[4-[2-[4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-1-methylindazol-6-yl]-3,3-difluoropiperidin-1-yl]acetyl]piperazin-1-yl]phenyl]-7-fluoro-3-oxo-1H-isoindol-2-yl]-N-pyridin-2-ylacetamide
CID 156515748
(2S)-2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-[5-[4-[4-[2-[4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-1-methylindazol-6-yl]piperidin-1-yl]acetyl]piperazin-1-yl]phenyl]-7-fluoro-3-oxo-1H-isoindol-2-yl]-N-pyridin-2-ylacetamide
CID 156515908
1-[6-[1-[2-[4-[4-[2-[1-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-(pyridin-2-ylamino)ethyl]-7-fluoro-3-oxo-1H-isoindol-5-yl]phenyl]piperazin-1-yl]-2-oxoethyl]-3,3-difluoropiperidin-4-yl]-1-methylindazol-3-yl]-1,3-diazinane-2,4-dione
CID 156516054
2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-[5-[4-[4-[2-[4-[3-(2,4-dioxo-1,3-diazinan-1-yl)-1-methylindazol-6-yl]piperidin-1-yl]acetyl]piperazin-1-yl]phenyl]-7-fluoro-3-oxo-1H-isoindol-2-yl]-N-(5-methyl-2-pyridinyl)acetamide
CID 156516239

Frequently Asked Questions

What is the IUPAC name of [(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-5-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-6-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-[1-(2-methoxyethyl)indol-2-yl]-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-(2-methylpropyl)indol-2-yl]benzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-[(1-methylpyrazol-4-yl)methyl]indol-2-yl]benzimidazol-5-yl]methanone?
The IUPAC name of [(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-5-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-6-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-[1-(2-methoxyethyl)indol-2-yl]-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-(2-methylpropyl)indol-2-yl]benzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-[(1-methylpyrazol-4-yl)methyl]indol-2-yl]benzimidazol-5-yl]methanone (CID 162151140) is [(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-5-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-6-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-[1-(2-methoxyethyl)indol-2-yl]-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-(2-methylpropyl)indol-2-yl]benzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-[(1-methylpyrazol-4-yl)methyl]indol-2-yl]benzimidazol-5-yl]methanone.
What is the SMILES notation for [(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-5-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-6-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-[1-(2-methoxyethyl)indol-2-yl]-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-(2-methylpropyl)indol-2-yl]benzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-[(1-methylpyrazol-4-yl)methyl]indol-2-yl]benzimidazol-5-yl]methanone?
The canonical SMILES for [(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-5-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-6-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-[1-(2-methoxyethyl)indol-2-yl]-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-(2-methylpropyl)indol-2-yl]benzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-[(1-methylpyrazol-4-yl)methyl]indol-2-yl]benzimidazol-5-yl]methanone is CC(C)Cn1c(-c2nc3cc(C(=O)N4CCC[C@@H](N)C4)ccc3n2C)cc2ccccc21.CCn1c(-c2nc3cc(C(=O)N4CCC[C@@H](N)C4)ccc3n2C)cc2cc(C)ccc21.CCn1c(-c2nc3cc(C(=O)N4CCC[C@@H](N)C4)ccc3n2C)cc2ccc(C)cc21.COCCn1c(-c2nc3cc(C(=O)N4CCC[C@@H](N)C4)ccc3n2C)cc2ccccc21.Cn1cc(Cn2c(-c3nc4cc(C(=O)N5CCC[C@@H](N)C5)ccc4n3C)cc3ccccc32)cn1.
What is the InChIKey of [(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-5-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-6-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-[1-(2-methoxyethyl)indol-2-yl]-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-(2-methylpropyl)indol-2-yl]benzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-[(1-methylpyrazol-4-yl)methyl]indol-2-yl]benzimidazol-5-yl]methanone?
The InChIKey is ZLFMSKUPMUXHAZ-UNMKSZRGSA-N. The full InChI is InChI=1S/C27H29N7O.C26H31N5O.C25H29N5O2.2C25H29N5O/c1-31-15-18(14-29-31)16-34-23-8-4-3-6-19(23)13-25(34)26-30-22-12-20(9-10-24(22)32(26)2)27(35)33-11-5-7-21(28)17-33;1-17(2)15-31-22-9-5-4-7-18(22)14-24(31)25-28-21-13-19(10-11-23(21)29(25)3)26(32)30-12-6-8-20(27)16-30;1-28-22-10-9-18(25(31)29-11-5-7-19(26)16-29)14-20(22)27-24(28)23-15-17-6-3-4-8-21(17)30(23)12-13-32-2;1-4-30-21-9-7-16(2)12-18(21)14-23(30)24-27-20-13-17(8-10-22(20)28(24)3)25(31)29-11-5-6-19(26)15-29;1-4-30-22-12-16(2)7-8-17(22)14-23(30)24-27-20-13-18(9-10-21(20)28(24)3)25(31)29-11-5-6-19(26)15-29/h3-4,6,8-10,12-15,21H,5,7,11,16-17,28H2,1-2H3;4-5,7,9-11,13-14,17,20H,6,8,12,15-16,27H2,1-3H3;3-4,6,8-10,14-15,19H,5,7,11-13,16,26H2,1-2H3;2*7-10,12-14,19H,4-6,11,15,26H2,1-3H3/t21-;20-;3*19-/m11111/s1.
What are the key properties of [(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-5-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-6-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-[1-(2-methoxyethyl)indol-2-yl]-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-(2-methylpropyl)indol-2-yl]benzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-[(1-methylpyrazol-4-yl)methyl]indol-2-yl]benzimidazol-5-yl]methanone?
[(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-5-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-6-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-[1-(2-methoxyethyl)indol-2-yl]-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-(2-methylpropyl)indol-2-yl]benzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-[(1-methylpyrazol-4-yl)methyl]indol-2-yl]benzimidazol-5-yl]methanone has a molecular weight of 2159.77 g/mol, XLogP of 19.53, 19 rotatable bonds, 5 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for [(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-5-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-(1-ethyl-6-methylindol-2-yl)-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[2-[1-(2-methoxyethyl)indol-2-yl]-1-methylbenzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-(2-methylpropyl)indol-2-yl]benzimidazol-5-yl]methanone;[(3R)-3-aminopiperidin-1-yl]-[1-methyl-2-[1-[(1-methylpyrazol-4-yl)methyl]indol-2-yl]benzimidazol-5-yl]methanone is sourced from PubChem (CID 162151140), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).